Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
3 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 18 Nov 2020
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).

Platelet-rich plasma injections safe, effective for female androgenetic alopecia

19 Oct 2020

Injections of platelet-rich plasma (PRP) with the Eclipse system confer a beneficial effect to women with androgenetic alopecia (AGA), with no serious adverse effects, a recent study has shown.

“PRP may be a useful treatment for AGA, although objective studies are needed,” the investigators said.

To determine whether PRP injections could improve female AGA, a prospective randomized controlled trial was conducted. Thirty women diagnosed with AGA participated in this study and received subdermal scalp injections of Eclipse system PRP or placebo saline at weeks 0, 4, and 8.

Outcome measures were changes in hair density (hair/cm2), hair calibre (mm), and blinded global photographic assessment (improved or not improved) at week 24.

In blinded global photographic assessment, 57 percent of patients on PRP, compared to 7 percent of those receiving saline, showed improvement at week 24 from baseline (p<0.01). Mean density in the PRP group compared to the placebo group also improved at week 8 (71.1 vs –26.7 hairs/cm2; p<0.01) and week 24 (105.9 vs –52.4 hairs/cm2; p<0.01) relative to baseline. An improvement was also noted in mean calibre in the PRP group compared to the placebo group at week 8 (0.0043 vs –0.0034 mm; p<0.01) and week 24 (0.0053 vs –0.0060 mm; p<0.01) relative to baseline.

Of note, the following adverse effects were observed: headache, swelling, redness, scalp tightness, and postinjection bleeding. Two patients were lost to follow-up, according to the investigators.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
3 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 18 Nov 2020
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).